1. Home
  2. USNA vs EYPT Comparison

USNA vs EYPT Comparison

Compare USNA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • EYPT
  • Stock Information
  • Founded
  • USNA 1992
  • EYPT 1987
  • Country
  • USNA United States
  • EYPT United States
  • Employees
  • USNA N/A
  • EYPT N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • USNA Health Care
  • EYPT Industrials
  • Exchange
  • USNA Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • USNA 565.5M
  • EYPT 741.0M
  • IPO Year
  • USNA 1996
  • EYPT 2005
  • Fundamental
  • Price
  • USNA $30.47
  • EYPT $13.35
  • Analyst Decision
  • USNA Hold
  • EYPT Strong Buy
  • Analyst Count
  • USNA 1
  • EYPT 6
  • Target Price
  • USNA $36.00
  • EYPT $25.83
  • AVG Volume (30 Days)
  • USNA 114.4K
  • EYPT 783.3K
  • Earning Date
  • USNA 10-21-2025
  • EYPT 11-06-2025
  • Dividend Yield
  • USNA N/A
  • EYPT N/A
  • EPS Growth
  • USNA N/A
  • EYPT N/A
  • EPS
  • USNA 1.80
  • EYPT N/A
  • Revenue
  • USNA $899,221,000.00
  • EYPT $51,898,000.00
  • Revenue This Year
  • USNA $13.94
  • EYPT N/A
  • Revenue Next Year
  • USNA $7.95
  • EYPT N/A
  • P/E Ratio
  • USNA $16.99
  • EYPT N/A
  • Revenue Growth
  • USNA 2.75
  • EYPT 2.99
  • 52 Week Low
  • USNA $23.10
  • EYPT $3.91
  • 52 Week High
  • USNA $41.84
  • EYPT $14.42
  • Technical
  • Relative Strength Index (RSI)
  • USNA 45.92
  • EYPT 63.75
  • Support Level
  • USNA $29.67
  • EYPT $13.19
  • Resistance Level
  • USNA $30.93
  • EYPT $14.42
  • Average True Range (ATR)
  • USNA 0.69
  • EYPT 0.77
  • MACD
  • USNA -0.15
  • EYPT 0.11
  • Stochastic Oscillator
  • USNA 30.38
  • EYPT 66.14

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: